These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 426859)

  • 1. Inhibition of neuronal uptake of 3H-biogenic amines into rat cerebral cortex by partially and fully saturated derivatives of imipramine and desipramine. The importance of the aromatic ring in adrenergic amines--part 3.
    Grunewald GL; Reitz TJ; Ruth JA; Vollmer S; Eiden LE; Rutledge CO
    Biochem Pharmacol; 1979; 28(3):417-21. PubMed ID: 426859
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 3. The phenyl rings of tricyclic antidepressants and related compounds as determinants of the potency of inhibition of the amine pumps in adrenergic neurons of the rabbit aorta and in rat cortical synaptosomes.
    Maxwell RA; Ferris RM; Burcsu J; Woodward EC; Tang D; Williard K
    J Pharmacol Exp Ther; 1974 Dec; 191(3):418-30. PubMed ID: 4427288
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 1-alkyl-1,2,3,4-tetrahydrocarbazole-1-ethanamines and related compounds, potential antidepressants, on biogenic amine uptake mechanisms.
    Puglsey TA; Lippmann W
    Experientia; 1977 Jan; 33(1):57-9. PubMed ID: 299847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
    Azzaro AJ; Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W; Pugsley TA
    Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lung, liver and brain monoamine oxidase by imipramine and desipramine.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1974 Mar; 23(6):1138-40. PubMed ID: 4824911
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 11. 'High affinity' binding of [3H]desipramine to rat cerebral cortex: relationship to tricyclic antidepressant-induced inhibition of norepinephrine uptake.
    Rehavi M; Skolnick P; Hulihan B; Paul SM
    Eur J Pharmacol; 1981 Apr; 70(4):597-9. PubMed ID: 7238579
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of transport for the uptake and release of biogenic amines in nerve endings.
    Bogdanski DF
    Adv Exp Med Biol; 1976; 69():291-305. PubMed ID: 133592
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of [3H]desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes.
    Lee CM; Javitch JA; Snyder SH
    J Neurosci; 1982 Oct; 2(10):1515-25. PubMed ID: 7119871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical properties of 3,3-dimethyl-1-[3-(methylamino) propyl]-1-phenylindan HCl (LU 3-049) and selected tricyclic antidepressants.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):317-29. PubMed ID: 849078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute and chronic treatment of tandamine, a new heterocyclic antidepressant, on biogenic amine metabolism and related activities.
    Pugsley TA; Lippmann W
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):239-47. PubMed ID: 503251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine).
    Clineschmidt BV; Totaro JA; Pflueger AB; McGuffin JC
    Pharmacol Res Commun; 1978 Mar; 10(3):219-28. PubMed ID: 684030
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
    Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.